Symposium
“Intelligent Oncology – The Potential of AI to Control Cancer“

MISSION

Bringing together experts from various disciplines to explore the latest advances in AI-assisted cancer research. Our goal is to promote collaboration between researchers, physicians, industry leaders, and other visionaries in the field. By sharing knowledge and expertise, we aim to discover new ways to control cancer through the power of AI.

AIM OF THE CONFERENCE

The theme of the conference is Intelligent Oncology, focusing on harnessing the power of AI to control cancer. Our aim is to present cutting-edge research and innovative approaches in cancer diagnosis, prognosis, and treatment. We aim to identify new research directions, foster collaborations between academia and industry, and facilitate the translation of research findings into clinical practice. By connecting experts in the field, we aim to accelerate progress towards more effective and personalized cancer treatment.

AREAS OF FOCUS

AI in cancer diagnosis/treatment

Computational methods for cancer research

Precision medicine with AI

Ethical, regulatory and governance issues of AI for health

Clinical translation of AI health interventions 

Innovative AI technologies/platforms

Interdisciplinary collaborations in cancer

SCIENTIFIC BOARD

Prof. Dr. Dr. Melanie Börries
CRIION Scientific Director Systems Medicine & Medical Center, University of Freiburg

Prof. Dr. Mascha Binder
CRIION Scientific Director Clinical Oncology & University Hospital Basel

Prof. Dr. Joschka Boedecker
CRIION Scientific Director AI & Department of Computer Science, University of Freiburg

Assoc. Prof. Victor Greiff
University of Oslo, Norway

Dr. Maria Kalweit
CRIION Head of Applied AI Research & Department of Computer Science, University of Freiburg

Dr. Gabriel Kalweit
CRIION Head of Fundamental AI Research & Department of Computer Science, University of Freiburg

Prof. Christoph Merten
EPFL, Switzerland

Dr. Jan Moritz Middeke
University Hospital Dresden, Germany

Prof. em. Dr. Dr. h.c. mult. Roland Mertelsmann
CEO Mertelsmann Foundation & Medical Center, University of Freiburg

Prof. Dr. Adriana Tomic
Boston University, USA

Prof. Dr. Evelyn Ullrich
Goethe University, Ullrich Lab – Laboratory for Experimental Immunology & Cell Therapy, Germany

Prof. Dr. Robert Zeiser
CRIION Scientific Director Translational Oncology & Medical Center, University of Freiburg

PROGRAM 2024

9:30 – 9:50
Introduction
(Roland Mertelsmann, Joschka Boedecker, CRIION Freiburg, Germany, Evelyn Ullrich, Goethe University, Ullrich Lab Frankfurt)

9:50 – 10:05
With Trustworthy and Applicable AI Towards Cancer Control (Maria Kalweit, CRIION, Freiburg, Germany)

10:30 – 12:10
Session 1: Understanding Cancer Through AI and Computational Biology
This session will explore how AI and computational biology can improve our understanding of cancer.
Chair: Adriana Tomic, Boston University, USA, Robert Zeiser, Univerisity of Freiburg, Germany

Knowledge-based machine learning to extract disease mechanisms from multi-omics data
(Julio Saez-Rodriguez, Universität Heidelberg, Germany)

Improving cell segmentation in spatial transcriptomics (Daniel Jones, Fred Hutch Cancer Center, USA)

Exploring mechanisms and functional heterogeneity in cellular immunotherapies targeting cancer via machine learning analysis of live-imaging (Maria Alieva, Instituto de Investigaciones Biomédicas de Madrid, Spain)

13:10 – 14:50
Session 2: Building Trust and Regulation in Artificial Intelligence Models for Medicine

This session will examine how to incorporate trust and regulatory to the development and deployment of AI and computational biology-powered cancer therapies.
Chair: Moritz Middeke, University Hospital Dresden, Germany, Ignacio Mastroleo, CRIION Freiburg, Germany

New regulatory thinking is needed for ‘at-the-patient-bedside’ AI-based personalised drug and cell therapies in precision oncology
(Prof. Steven Gilbert, Technische Universität Dresden, Germany )

A regulator’s perspective on AI-based indications for anti-cancer medicines (Harald Enzmann, BFARM, Germany)

 15:20 – 17:10
Session 3: Deploying AI and Computational Biology into Clinical Applications
In this session, speakers will discuss the challenges and opportunities of translating AI and computational biology into clinical practice for cancer diagnosis, prognosis, and treatment.
Chair: Christoph Merten, EPFL, Switzerland, Melanie Börries, University of Freiburg, Germany

The practical usage of AI Applications in routine diagnostics (Sven Maschek, MLL Münchner Leukämieabor, Germany)

AI for better Cancer Care (Andre Dekker, Maastricht University Medical Center, Netherlands)

Machine Learning for Personalized Cancer Care (Adam Yala, Berkeley, USA)

REGISTRATION

Credits

You receive 8 credits from Landesärztekammer Baden – Württemberg.

SPEAKERS

Prof. Adam Yala

Berkeley and UCSF, USA

Dr. Andre Dekker

Maastricht University Medical
Center, Netherlands

Dr. Maria Alieva

Instituto de Investigaciones Biomédicas de Madrid, Spain

Dr. Harald Enzmann

BfArM, Germany

Prof. Julio Saez-Rodriguez

Universität Heidelberg, Germany

Prof. Steven Gilbert

Technische Universität Dresden, Germany

Sven Maschek

MLL Münchener Leukämielabor, Germany

Sponsors & Partners 2024

RECORDINGS OF THE PAST MEETING

If you like to receive the password, please contact sina.reis@comeed.ch

IMPRESSIONS OF THE PAST MEETING

To get the password please contact: sina.reis@comeed.ch